AptarGroup, Inc. (ATR) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped ATR stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: AptarGroup (ATR) represents an elite specialty packaging compounder operating primarily as a mission-critical pharmaceutical drug delivery developer with defensive consumer dispensing operations. Trading at $130.64 with an $8.1B market capitalization, the company trades at a reasonable valuation given its extraordinary track record of eight consecutive quarters of earnings beats and an average EPS surprise of +5.9%. While near-term top-line revenue growth appears subdued at 1.4% due to customer inventory pacing in retail segments, Aptar's high-margin Pharma division continues to capture share in specialized nasal, injectable, and vaccine delivery. With Wall Street targeting $150.80-$154.00 (+15.4% median upside), Aptar's asymmetric risk/reward is backed by significant regulatory IP barriers, solid dividend growth (recently hiked to $0.50 per share), and sustained expansion in high-barrier biologics delivery systems. The saved 1-year distribution is P10 $110, P50 $149.5, and P90 $172.
Last analyzed · Model: gemini-3.8-flash
AptarGroup, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $110 | Pessimistic plausible scenario |
| P50 | $149.5 | Median scenario |
| P90 | $172 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
AptarGroup possesses a formidable high-margin moat in proprietary pharmaceutical drug delivery devices and specialty packaging. An eight-quarter earnings beat streak, an ongoing +5.9% average EPS surprise, steady dividend growth, and an analyst consensus pointing toward $154 median targets provide strong near-term valuation support despite modest top-line organic volume recovery in consumer packaging.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this ATR analysis generated?
October 30, 2026.
Is this a guaranteed ATR prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full ATR stock analysis · ATR sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.